Denali Therapeutics Inc

-

Assets, Funds, Holdings

Home | Sign Up | Log In
New Features
Latest Fund Raises
Related People
Fund Service Providers
Startup & Company Raises
List of Funds
Boston Firms
Boston Hedge Funds
Cornell Alumni Firms
CalPERS Portfolio
NYSCRF Portfolio
User Guide
Regulatory AUM vs AUM
LP Portfolios
Related Firms
Build a Portfolio
Comprehensive Search
Keyboard
Denali Therapeutics Inc
CIK #0001714899
EDGAR Form CIK 2011 - 2026
10-K [0001714899]
10-Q [0001714899]
3 [0001714899]
4 [0001714899]
5 [0001714899]
8-K [0001714899]
D [0001714899]
SC 13G [0001714899]
Form 13D/13G Filer Form 13D/13G Subject Filed
T Rowe Price Investment Management Inc Denali Therapeutics Inc [2026-05-15]
Capital Research Global Investors Denali Therapeutics Inc [2024-11-12]
FMR LLC Denali Therapeutics Inc [2024-08-16]
Wellington Management Group LLP Denali Therapeutics Inc [2024-02-08]
Temasek Holdings Private Ltd Denali Therapeutics Inc [2023-03-30]
Price T Rowe Associates Inc /MD/ Denali Therapeutics Inc [2021-02-16]
BlackRock Inc Denali Therapeutics Inc [2021-02-02]
Biogen Inc Denali Therapeutics Inc [2020-09-28]
BlackRock Inc Denali Therapeutics Inc [2020-02-07]
Vanguard Group Inc Denali Therapeutics Inc [2019-02-11]
View All
Form 3/4/5 Subject 2011 - 2026
Baker Brothers Life Sciences LP
Baker Bros Advisors GP LLC
667 LP
Baker Julian
Baker Felix
Denali Therapeutics Inc
Baker Bros Advisors LP
Flatley Jay T
Krognes Steve E
Cook Jennifer E
Thornberry Nancy
Schenkein David P
Klein Peter S
van Hauwermeiren Timothy
Chin Peter Scott
Schuth Alexander O
Watts Ryan J
Ho Carole
Tessier-Lavigne Marc
Sato Vicki L
Harris Erik
Cole Douglas G
Nelsen Robert
Crestline Management LP
Bratton Douglas K
Crestline Investors Inc
Crestline SI GP LP
AKDL LP
Bratton Capital Inc
Bratton Capital Management LP
Neuro Line Partners LP
Biogen MA Inc
Biogen Inc
Arch Venture Partners VIII LP
Bybee Clinton
Arch Venture Partners VIII LLC
Arch Venture Fund VIII LP
Crandell Keith
FMR LLC
FIL Ltd
Flagship Ventures Fund V LP
Afeyan Noubar
Flagship Ventures Fund V General Partner LLC
Insider Transaction (Form 3/4/5) Date Action Shares Price Value ($)
Denali Therapeutics Inc DNLI
Common Stock
2026-01-06 Sell 17,218 $16.50 284,097
Denali Therapeutics Inc DNLI
Common Stock
2026-01-06 Sell 35,198 $16.50 580,767
Denali Therapeutics Inc DNLI
Common Stock
2026-01-03 Grant 57,700 $0.00
Denali Therapeutics Inc DNLI
Common Stock
2026-01-03 Grant 78,960 $0.00
Denali Therapeutics Inc DNLI
Stock Option (right to buy) · derivative
2026-01-03 Grant 236,880 $0.00
Denali Therapeutics Inc DNLI
Stock Option (right to buy) · derivative
2026-01-03 Grant 173,100 $0.00
Denali Therapeutics Inc DNLI
$0.01 Prefunded Warrants · derivative
2025-12-11 Buy 2,095,191 $17.49 36,644,891
Denali Therapeutics Inc DNLI
$0.01 Prefunded Warrants · derivative
2025-12-11 Buy 190,523 $17.49 3,332,247
Denali Therapeutics Inc DNLI
Stock Option (right to buy) · derivative
2025-11-04 Grant 31,897 $0.00
Denali Therapeutics Inc DNLI
Common Stock
2025-11-04 Grant 10,632 $0.00
Denali Therapeutics Inc DNLI
Common Stock
2025-08-13 Sell 806 $14.64 11,800
Denali Therapeutics Inc DNLI
Common Stock
2025-08-12 Sell 2,937 $13.58 39,884
Denali Therapeutics Inc DNLI
Common Stock
2025-08-12 Sell 2,937 $13.58 39,884
Denali Therapeutics Inc DNLI
Stock Option (right to buy) · derivative
2025-08-05 Option exercise 44,655 $0.00
Denali Therapeutics Inc DNLI
Common Stock
2025-08-05 Option exercise 44,655 $0.68 30,365
Denali Therapeutics Inc DNLI
Common Stock
2025-07-09 Sell 495,282 $15.00 7,429,230
Denali Therapeutics Inc DNLI
Stock Option (right to buy) · derivative
2025-07-09 Option exercise 40,000 $0.00
Denali Therapeutics Inc DNLI
Common Stock
2025-07-09 Option exercise 455,282 $0.68 309,592
Denali Therapeutics Inc DNLI
Stock Option (right to buy) · derivative
2025-07-09 Option exercise 455,282 $0.00
Denali Therapeutics Inc DNLI
Common Stock
2025-07-09 Option exercise 40,000 $5.28 211,200
showing 20 of 200 most recent transactions
Terms | Privacy | Providers | Companies | Guide
tony@aum13f.com